CTSK and breast cancer: The PEGylated cathepsin K-, L-, and S-targeted qSBP probe LUM015, designed by Whitley et al., exhibited an increased fluorescence signal ex vivo in breast cancer compared with normal muscle tissue in an orthotopic mouse model [141].